ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 170

Association Of BMI, 8 SNPs Reported To Be Related To Gout Phenotype and Their Interaction In Gout Incidence In Framingham Heart Study

Jasvinder A. Singh1,2, Ana Vazquez3, Richard Reynolds3, Vinodh Srinivasasainagendra4, S. Louis Bridges Jr.5 and David Allison3, 1Rheumatology, Birmingham VA, Birmingham, AL, 2Department of Medicine, University of Alabama, Tuscaloosa, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4University of alabama at birmingham, birmingham, AL, 5Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: body mass, Genetic Biomarkers, gout, obesity and population studies

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: We aim to assess the association of 8 serum urate SNPs and BMI and their interactions with incident gout in a population-based cohort study.

Methods: We used the Framingham Study including subject from the Original and the Offspring cohort (N=4,967). We assessed the effect of 8 SNPs in the recently described genetic urate score on incident gout. Subjects were genotyped with Affy500K platform, and two of the SNPs associated to gout rs1165196 and rs1106766 were present in that platform. The SNPs rs1967017, rs780093, rs13129697, rs2199936, rs675209 and rs2078267 were not present in the Affy SNP array, thus we imputed them with IMPUTE2. BMI was taken at the time of gout or, at the time of censoring if the subject is healthy or died without gout. We fitted logistic regression models to assess the associations. Estimated effects in the liability scale, odd ratios, and p-values are reported for all SNPs, covariates, and interactions. 408 patients had incident gout (74% males), with 169 from the FHS original cohort and 293 from the Offspring cohort.

Results: In a model with main effects of BMI and SNPs, three of eight SNPs and BMI were significantly associated with incident gout (p<=0.008 for all). Zero SNPs showed significant main effects on gout in the model that adjusted for all BMI*SNP interaction terms. However, BMI remained significant (p=0.003) and the rs2199936*BMI interaction was nearly significant (p=0.06). Gender and duration of follow-up were also significant predictors (p<=0.009) in all models.

Conclusion: SNPs known to predict urate levels moderated the association of BMI with gout, suggesting the possibility that the extent to which BMI increases the risk for got may depend on a person’s a priori genetic risk for high urate levels.


Disclosure:

J. A. Singh,

Takeda, Savient,

2,

Savient, Takeda, Ardea, Regeneron, Allergan,

5,

URL pharmaceuicals Novartis,

5;

A. Vazquez,
None;

R. Reynolds,
None;

V. Srinivasasainagendra,
None;

S. L. Bridges Jr.,
None;

D. Allison,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-bmi-8-snps-reported-to-be-related-to-gout-phenotype-and-their-interaction-in-gout-incidence-in-framingham-heart-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology